Azimuth Capital Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,813
| Closed | -$9.44M | – | 307 |
|
|
2024
Q4 | $9.44M | Sell |
28,813
-94
| -0.3% | -$30.8K | 0.37% | 91 |
|
|
2024
Q3 | $8.68M | Sell |
28,907
-1,550
| -5% | -$465K | 0.34% | 102 |
|
|
2024
Q2 | $10M | Sell |
30,457
-569
| -2% | -$187K | 0.41% | 74 |
|
|
2024
Q1 | $12.3M | Sell |
31,026
-1,536
| -5% | -$608K | 0.51% | 63 |
|
|
2023
Q4 | $11.5M | Sell |
32,562
-266
| -0.8% | -$93.7K | 0.52% | 65 |
|
|
2023
Q3 | $12.3M | Sell |
32,828
-196
| -0.6% | -$73.5K | 0.61% | 55 |
|
|
2023
Q2 | $12.6M | Sell |
33,024
-472
| -1% | -$181K | 0.6% | 54 |
|
|
2023
Q1 | $11.6M | Sell |
33,496
-1,550
| -4% | -$537K | 0.57% | 59 |
|
|
2022
Q4 | $8.25M | Buy |
35,046
+9,222
| +36% | +$2.17M | 0.42% | 74 |
|
|
2022
Q3 | $6.36M | Buy |
25,824
+306
| +1% | +$75.3K | 0.35% | 102 |
|
|
2022
Q2 | $7.72M | Buy |
+25,518
| New | +$7.72M | 0.39% | 87 |
|